Predictive factors of response to rituximab therapy in rheumatoid arthritis: What do we know today?
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference34 articles.
1. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis;Edwards;N Engl J Med,2004
2. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks;Cohen;Arthritis Rheum,2006
3. Long term treatment of rheumatoid arthritis with rituximab;Caporali;Autoimmun Rev,2009
4. What is the role of rituximab in the treatment of rheumatoid arthritis?;Atzeni;Autoimmun Rev,2007
5. Strategies after failure of the first anti-tumor necrosis factor α agent in rheumatoid arthritis;Papagoras;Autoimmun Rev,2010
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A comparison of rituximab with cyclophosphamide in terms of efficacy and complications as induction therapy for treating granulomatosis with polyangiitis: A three-center study;European Journal of Rheumatology;2022-04-29
2. Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire;Annals of the Rheumatic Diseases;2019-06-19
3. Treatment of primary Sjögren’s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity;Annals of the Rheumatic Diseases;2019-03-02
4. The multi-biomarker disease activity score tracks response to rituximab treatment in rheumatoid arthritis patients: a post hoc analysis of three cohort studies;Arthritis Research & Therapy;2018-11-20
5. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews;Health Technology Assessment;2018-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3